CD82 and prostate cancer: On the other hand, suppression of NDRG1-mediated metastasis occurs upon loss of KAI1 expression in vitro and in vivo, demonstrating that KAI1 is a functional downstream target of the NDRG1 pathway on prostate cancer[179].